{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T21:05:20Z","timestamp":1793480720256,"version":"4.5.0"},"reference-count":263,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"abstract":"<jats:title>This Technical Report was revised. See https:\/\/doi.org\/10.1542\/peds.2025-072218.<\/jats:title>\n                  <jats:p>A working knowledge of contraception will assist the pediatrician in both sexual health promotion as well as treatment of common adolescent gynecologic problems. Best practices in adolescent anticipatory guidance and screening include a sexual health history, screening for pregnancy and sexually transmitted infections, counseling, and if indicated, providing access to contraceptives. Pediatricians\u2019 long-term relationships with adolescents and families allow them to help promote healthy sexual decision-making, including abstinence and contraceptive use. Additionally, medical indications for contraception, such as acne, dysmenorrhea, and heavy menstrual bleeding, are frequently uncovered during adolescent visits. This technical report provides an evidence base for the accompanying policy statement and addresses key aspects of adolescent contraceptive use, including the following: (1) sexual history taking, confidentiality, and counseling; (2) adolescent data on the use and side effects of newer contraceptive methods; (3) new data on older contraceptive methods; and (4) evidence supporting the use of contraceptives in adolescent patients with complex medical conditions.<\/jats:p>","DOI":"10.1542\/peds.2014-2300","type":"journal-article","created":{"date-parts":[[2014,9,30]],"date-time":"2014-09-30T00:24:19Z","timestamp":1412036659000},"page":"e1257-e1281","source":"Crossref","is-referenced-by-count":218,"title":["Contraception for Adolescents"],"prefix":"10.1542","volume":"134","author":[{"given":"Mary A.","family":"Ott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gina S.","family":"Sucato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COMMITTEE ON ADOLESCENCE","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula K.","family":"Braverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Adelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Alderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora C.","family":"Breuner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arik V.","family":"Marcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca F.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"2025071714260425500_B1","article-title":"Policy statement: contraception for adolescents.","author":"American Academy of Pediatrics, Committee on Adolescence","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"2025071714260425500_B2","first-page":"1","article-title":"Youth risk behavior surveillance - United States, 2011.","volume":"61","author":"Eaton","year":"2012","journal-title":"MMWR Surveill Summ"},{"key":"2025071714260425500_B3"},{"issue":"5","key":"2025071714260425500_B4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.contraception.2011.07.013","article-title":"Unintended pregnancy in the United States: incidence and disparities, 2006.","volume":"84","author":"Finer","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B5","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2105\/AJPH.2006.089169","article-title":"Explaining recent declines in adolescent pregnancy in the United States: the contribution of abstinence and improved contraceptive use.","volume":"97","author":"Santelli","year":"2007","journal-title":"Am J Public Health"},{"issue":"30","key":"2025071714260425500_B6","first-page":"1","article-title":"Teenagers in the United States: sexual activity, contraceptive use, and childbearing, national survey of family growth 2006-2008.","author":"Abma","year":"2010","journal-title":"Vital Health Stat 23"},{"key":"2025071714260425500_B7","volume-title":"Bright Futures: Guidelines for Health Supervision of Infants, Children, and Adolescents","author":"Hagan","year":"2008","edition":"3rd ed."},{"key":"2025071714260425500_B8","volume-title":"State Minor Consent Laws: A Summary","author":"Center for Adolescent Health and the Law","year":"2010","edition":"3rd ed."},{"key":"2025071714260425500_B9","unstructured":"Guttmacher Institute. An Overview of Minors' Consent Law as of January 1, 2014. State Policies in Brief as of June 1, 2014. Available at: www.guttmacher.org\/statecenter\/spibs\/spib_MACS.pdf. Accessed June 20, 2014"},{"issue":"2","key":"2025071714260425500_B10","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1363\/3608004","article-title":"The HIPAA privacy rule and adolescents: legal questions and clinical challenges.","volume":"36","author":"English","year":"2004","journal-title":"Perspect Sex Reprod Health"},{"issue":"3","key":"2025071714260425500_B11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1542\/peds.2006-3527","article-title":"Special requirements of electronic health record systems in pediatrics.","volume":"119","author":"Spooner","year":"2007","journal-title":"Pediatrics"},{"issue":"12","key":"2025071714260425500_B12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jama.1997.03550120089044","article-title":"Influence of physician confidentiality assurances on adolescents\u2019 willingness to disclose information and seek future health care. A randomized controlled trial.","volume":"278","author":"Ford","year":"1997","journal-title":"JAMA"},{"issue":"3","key":"2025071714260425500_B13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jadohealth.2006.09.015","article-title":"Forgone health care among U.S. adolescents: associations between risk characteristics and confidentiality concern.","volume":"40","author":"Lehrer","year":"2007","journal-title":"J Adolesc Health"},{"issue":"2","key":"2025071714260425500_B14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jadohealth.2005.12.002","article-title":"Understanding confidentiality: perspectives of African American adolescents and their parents.","volume":"39","author":"Lyren","year":"2006","journal-title":"J Adolesc Health"},{"issue":"6","key":"2025071714260425500_B15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2007-0351","article-title":"Voices of Asian American youth: important characteristics of clinicians and clinical sites.","volume":"120","author":"Vo","year":"2007","journal-title":"Pediatrics"},{"issue":"6","key":"2025071714260425500_B16","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/archpedi.157.6.523","article-title":"Improving participation in Chlamydia screening programs: perspectives of high-risk youth.","volume":"157","author":"Blake","year":"2003","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"1","key":"2025071714260425500_B17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2013-1282","article-title":"Office-based care for lesbian, gay, bisexual, transgender, and questioning youth.","volume":"132","author":"Committee On Adolescence","year":"2013","journal-title":"Pediatrics"},{"issue":"7","key":"2025071714260425500_B18","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/archpedi.152.7.676","article-title":"Adolescents\u2019 access to care: teenagers\u2019 self-reported use of services and perceived access to confidential care.","volume":"152","author":"Klein","year":"1998","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"2025071714260425500_B19","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jama.288.6.710","article-title":"Effect of mandatory parental notification on adolescent girls\u2019 use of sexual health care services.","volume":"288","author":"Reddy","year":"2002","journal-title":"JAMA"},{"issue":"3","key":"2025071714260425500_B20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0197-0070(91)90015-E","article-title":"Reasons for delay in contraceptive clinic utilization. Adolescent clinic and nonclinic populations compared.","volume":"12","author":"Zabin","year":"1991","journal-title":"J Adolesc Health"},{"issue":"4","key":"2025071714260425500_B21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1353\/dem.0.0026","article-title":"Fertility effects of abortion and birth control pill access for minors.","volume":"45","author":"Guldi","year":"2008","journal-title":"Demography"},{"issue":"8","key":"2025071714260425500_B22","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.2105\/AJPH.94.8.1347","article-title":"Fertility and parental consent for minors to receive contraceptives.","volume":"94","author":"Zavodny","year":"2004","journal-title":"Am J Public Health"},{"key":"2025071714260425500_B23"},{"issue":"3","key":"2025071714260425500_B24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jama.293.3.340","article-title":"Adolescents\u2019 reports of parental knowledge of adolescents\u2019 use of sexual health services and their reactions to mandated parental notification for prescription contraception.","volume":"293","author":"Jones","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"2025071714260425500_B25","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jadohealth.2010.07.019","article-title":"How do adolescents view health? Implications for state health policy.","volume":"48","author":"Ott","year":"2011","journal-title":"J Adolesc Health"},{"issue":"1","key":"2025071714260425500_B26","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s13178-011-0039-0","article-title":"The more things change\u2026: the relative importance of the Internet as a source of contraceptive information for teens.","volume":"8","author":"Jones","year":"2011","journal-title":"Sexual Research and Social Policy"},{"issue":"1","key":"2025071714260425500_B27","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jadohealth.2008.06.018","article-title":"Discussion of sensitive health topics with youth during primary care visits: relationship to youth perceptions of care.","volume":"44","author":"Brown","year":"2009","journal-title":"J Adolesc Health"},{"key":"2025071714260425500_B28","volume-title":"A Guide to Taking a Sexual History","author":"Centers for Disease Control and Prevention","year":"2005"},{"issue":"6","key":"2025071714260425500_B29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jadohealth.2008.10.139","article-title":"\u201cThat\u2019s nasty\u201d to curiosity: early adolescent cognitions about sexual abstinence.","volume":"44","author":"Ott","year":"2009","journal-title":"J Adolesc Health"},{"issue":"4","key":"2025071714260425500_B30","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archpediatrics.2010.16","article-title":"Cost-effectiveness of a motivational intervention to reduce rapid repeated childbearing in high-risk adolescent mothers: a rebirth of economic and policy considerations.","volume":"164","author":"Barnet","year":"2010","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"13","key":"2025071714260425500_B31","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1001\/jama.280.13.1161","article-title":"Efficacy of risk-reduction counseling to prevent human immunodeficiency virus and sexually transmitted diseases: a randomized controlled trial.","volume":"280","author":"Kamb","year":"1998","journal-title":"JAMA"},{"key":"2025071714260425500_B32"},{"issue":"12","key":"2025071714260425500_B33","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/archpedi.159.12.1173","article-title":"Brief interventions and motivational interviewing with children, adolescents, and their parents in pediatric health care settings: a review.","volume":"159","author":"Erickson","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"5","key":"2025071714260425500_B34","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S1054-139X(97)00261-9","article-title":"Healthy youth development as a model for youth health promotion. A review.","volume":"22","author":"Blum","year":"1998","journal-title":"J Adolesc Health"},{"issue":"1","key":"2025071714260425500_B35","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpag.2006.10.013","article-title":"Counseling adolescents about abstinence in the office setting.","volume":"20","author":"Ott","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"2","key":"2025071714260425500_B36","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1363\/3808406","article-title":"Greater expectations: adolescents\u2019 positive motivations for sex.","volume":"38","author":"Ott","year":"2006","journal-title":"Perspect Sex Reprod Health"},{"issue":"2","key":"2025071714260425500_B37","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jadohealth.2005.12.009","article-title":"Perceptions of sexual abstinence among high-risk early and middle adolescents.","volume":"39","author":"Ott","year":"2006","journal-title":"J Adolesc Health"},{"key":"2025071714260425500_B38","volume-title":"Motivational Interviewing with Adolescents and Young Adults","author":"Naar-King","year":"2010"},{"issue":"1","key":"2025071714260425500_B39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/109019810102800102","article-title":"A relative risk-based, disease-specific definition of sexual abstinence failure rates.","volume":"28","author":"Pinkerton","year":"2001","journal-title":"Health Educ Behav"},{"issue":"4","key":"2025071714260425500_B40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jadohealth.2005.01.005","article-title":"After the promise: the STD consequences of adolescent virginity pledges.","volume":"36","author":"Br\u00fcckner","year":"2005","journal-title":"J Adolesc Health"},{"key":"2025071714260425500_B41","volume-title":"Contraceptive Technology","author":"Hatcher","year":"2011","edition":"20th rev ed."},{"key":"2025071714260425500_B42","first-page":"1","article-title":"US selected practice recommendations for contraceptive use, 2013.","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Recomm Rep"},{"issue":"6","key":"2025071714260425500_B43","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.contraception.2012.02.009","article-title":"Update on and correction to the cost-effectiveness of contraceptives in the United States.","volume":"85","author":"Trussell","year":"2012","journal-title":"Contraception"},{"key":"2025071714260425500_B44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/13625180801942754","article-title":"The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience.","volume":"13","author":"Graesslin","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"5","key":"2025071714260425500_B45","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2008.06.016","article-title":"Implanon US Study Group. Assessment of Implanon insertion and removal","volume":"78","author":"Levine","year":"2008","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.contraception.2007.03.012","article-title":"Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases.","volume":"76","author":"Vidin","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B47","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ajog.2005.09.016","article-title":"Nerve injury caused by removal of an implantable hormonal contraceptive.","volume":"195","author":"Wechselberger","year":"2006","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2025071714260425500_B48","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.contraception.2010.02.010","article-title":"Etonogestrel implant in postpartum adolescents: bleeding pattern, efficacy and discontinuation rate.","volume":"82","author":"Guazzelli","year":"2010","journal-title":"Contraception"},{"issue":"5","key":"2025071714260425500_B49","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.contraception.2009.12.006","article-title":"Implanon as a contraceptive choice for teenage mothers: a comparison of contraceptive choices, acceptability and repeat pregnancy.","volume":"81","author":"Lewis","year":"2010","journal-title":"Contraception"},{"issue":"4","key":"2025071714260425500_B50","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.contraception.2006.05.072","article-title":"Continuation rates of Implanon in the UK: data from an observational study in a clinical setting.","volume":"74","author":"Lakha","year":"2006","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B51","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.contraception.2009.05.132","article-title":"Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia.","volume":"80","author":"Harvey","year":"2009","journal-title":"Contraception"},{"issue":"5","key":"2025071714260425500_B52","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.fertnstert.2008.02.140","article-title":"Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials.","volume":"91","author":"Darney","year":"2009","journal-title":"Fertil Steril"},{"issue":"13","key":"2025071714260425500_B53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns.","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"3","key":"2025071714260425500_B54","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.contraception.2010.08.001","article-title":"The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users.","volume":"83","author":"Mansour","year":"2011","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/humrep\/15.1.118","article-title":"Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception.","volume":"15","author":"Beerthuizen","year":"2000","journal-title":"Hum Reprod"},{"issue":"2","key":"2025071714260425500_B56","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/humrep\/dei358","article-title":"A prospective study of the forearm bone density of users of etonorgestrel- and levonorgestrel-releasing contraceptive implants.","volume":"21","author":"Bahamondes","year":"2006","journal-title":"Hum Reprod"},{"issue":"3","key":"2025071714260425500_B57","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijgo.2010.01.018","article-title":"Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years.","volume":"109","author":"Pongsatha","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"2025071714260425500_B58","first-page":"1","article-title":"US medical eligibility criteria for contraceptive use, 2010.","volume":"59","author":"Centers for Disease Control and Prevention","year":"2010","journal-title":"MMWR Recomm Rep"},{"issue":"1","key":"2025071714260425500_B59","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/AOG.0b013e318227f05e","article-title":"ACOG Practice Bulletin No. 121: Long-acting reversible contraception: implants and intrauterine devices.","volume":"118","author":"American College of Obstetricians and Gynecologists","year":"2011","journal-title":"Obstet Gynecol"},{"key":"2025071714260425500_B60","unstructured":"Skyla [package insert]. Wayne, NJ: Bayer HealthCare Pharmaceuticals; 2013. Available at: http:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Skyla_PI.pdf. Accessed January 15, 2014"},{"key":"2025071714260425500_B61","unstructured":"Mirena [package insert]. Wayne, NJ: Bayer HealthCare Pharmaceuticals; 2013. Available at: http:\/\/labeling.bayerhealthcare.com\/html\/products\/pi\/Mirena_PI.pdf. Accessed January 15, 2014"},{"key":"2025071714260425500_B62","unstructured":"Paragard [package insert]. Sellersville, PA: Teva Woman\u2019s Health Inc\/Teva Pharmaceuticals; 2011. Available at: http:\/\/paragard.com\/Pdf\/ParaGard-PI.pdf. June 22, 2104"},{"issue":"6","key":"2025071714260425500_B63","first-page":"341","article-title":"Long-term reversible contraception. Twelve years of experience with the TCu380A and TCu220C.","volume":"56","year":"1997","journal-title":"Contraception"},{"issue":"4","key":"2025071714260425500_B64","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.fertnstert.2012.06.027","article-title":"Changes in use of long-acting contraceptive methods in the United States, 2007\u20132009.","volume":"98","author":"Finer","year":"2012","journal-title":"Fertil Steril"},{"issue":"8","key":"2025071714260425500_B65","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1056\/NEJMoa010438","article-title":"Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women.","volume":"345","author":"Hubacher","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"2025071714260425500_B66","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2006.09.010","article-title":"Use of IUD and subsequent fertility\u2014follow-up after participation in a randomized clinical trial.","volume":"75","author":"Hov","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1783\/147118904322701956","article-title":"FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception.","volume":"30","author":"Penney","year":"2004","journal-title":"J Fam Plann Reprod Health Care"},{"issue":"2","key":"2025071714260425500_B68","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.contraception.2005.08.007","article-title":"Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review.","volume":"73","author":"Mohllajee","year":"2006","journal-title":"Contraception"},{"issue":"8796","key":"2025071714260425500_B69","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0140-6736(92)91904-M","article-title":"Intrauterine devices and pelvic inflammatory disease: an international perspective.","volume":"339","author":"Farley","year":"1992","journal-title":"Lancet"},{"issue":"9234","key":"2025071714260425500_B70","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S0140-6736(00)02699-4","article-title":"Intrauterine device and upper-genital-tract infection.","volume":"356","author":"Grimes","year":"2000","journal-title":"Lancet"},{"key":"2025071714260425500_B71","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/j.contraception.2006.12.005","article-title":"Copper intrauterine device use by nulliparous women: review of side effects.","volume":"75","author":"Hubacher","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B72","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/02699200802253706","article-title":"Experience of IUD\/IUS insertions and clinical performance in nulliparous women\u2014a pilot study.","volume":"13","author":"Brockmeyer","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"issue":"10","key":"2025071714260425500_B73","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/humrep\/del208","article-title":"Risk factors for IUD failure: results of a large multicentre case-control study.","volume":"21","author":"Thonneau","year":"2006","journal-title":"Hum Reprod"},{"issue":"5","key":"2025071714260425500_B74","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.contraception.2003.11.008","article-title":"Clinical performance of a levonorgestrel-releasing intrauterine system and oral contraceptives in young nulliparous women: a comparative study.","volume":"69","author":"Suhonen","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"2025071714260425500_B75","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.contraception.2009.09.004","article-title":"Intrauterine contraception for adolescents aged 14-18 years: a multicenter randomized pilot study of levonorgestrel-releasing intrauterine system compared to the Copper T 380A.","volume":"81","author":"Godfrey","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B76","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.contraception.2008.12.001","article-title":"A nationwide cohort study of the use of the levonorgestrel intrauterine device in New Zealand adolescents.","volume":"79","author":"Paterson","year":"2009","journal-title":"Contraception"},{"issue":"2","key":"2025071714260425500_B77","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1471-0528.2009.02372.x","article-title":"The levonorgestrel intrauterine system (Mirena) for the treatment of menstrual problems in adolescents with medical disorders, or physical or learning disabilities.","volume":"117","author":"Pillai","year":"2010","journal-title":"BJOG"},{"issue":"4","key":"2025071714260425500_B78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jpag.2006.05.005","article-title":"Revisiting the intrauterine contraceptive device in adolescents.","volume":"19","author":"Toma","year":"2006","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"1","key":"2025071714260425500_B79","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jpag.2010.07.001","article-title":"Intrauterine contraception in adolescents and young women: a descriptive study of use, side effects, and compliance.","volume":"24","author":"Lara-Torre","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"2025071714260425500_B80","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jpag.2012.05.005","article-title":"Menstrual suppression with the levonorgestrel intrauterine system in girls with developmental delay.","volume":"25","author":"Hillard","year":"2012","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"2025071714260425500_B81","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/jwh.2010.2462","article-title":"Menstrual concerns and intrauterine contraception among adolescent bariatric surgery patients.","volume":"20","author":"Hillman","year":"2011","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"2025071714260425500_B82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.contraception.2009.02.005","article-title":"Subcutaneous DMPA vs. intramuscular DMPA: a 2-year randomized study of contraceptive efficacy and bone mineral density.","volume":"80","author":"Kaunitz","year":"2009","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B83","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/AOG.0b013e318188d1ec","article-title":"ACOG Committee Opinion No. 415: Depot medroxyprogesterone acetate and bone effects.","volume":"112","author":"American College of Obstetricians and Gynecologists Committee on Gynecologic Practice","year":"2008","journal-title":"Obstet Gynecol"},{"key":"2025071714260425500_B84","first-page":"419","article-title":"Depot medroxyprogesterone acetate contraception and the risk of breast and gynecologic cancer.","volume":"41","author":"Kaunitz","year":"1996","journal-title":"J Reprod Med"},{"issue":"1","key":"2025071714260425500_B85","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2008.12.014","article-title":"An evidence-based approach to postpartum use of depot medroxyprogesterone acetate in breastfeeding women.","volume":"80","author":"Rodriguez","year":"2009","journal-title":"Contraception"},{"issue":"9","key":"2025071714260425500_B86","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1212\/WNL.52.9.1917-a","article-title":"Progesterone therapy in women with epilepsy: a 3-year follow-up.","volume":"52","author":"Herzog","year":"1999","journal-title":"Neurology"},{"issue":"5","key":"2025071714260425500_B87","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0010-7824(97)00156-X","article-title":"Effect of Depo-Provera or Microgynon on the painful crises of sickle cell anemia patients.","volume":"56","author":"de Abood","year":"1997","journal-title":"Contraception"},{"issue":"2","key":"2025071714260425500_B88","first-page":"CD006261","article-title":"Steroid hormones for contraception in women with sickle cell disease.","author":"Manchikanti","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"2025071714260425500_B89","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/ATVBAHA.110.211482","article-title":"The risk of deep venous thrombosis associated with injectable depot-medroxyprogesterone acetate contraceptives or a levonorgestrel intrauterine device.","volume":"30","author":"van Hylckama Vlieg","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"2 pt 2","key":"2025071714260425500_B90","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/AOG.0b013e318213cd49","article-title":"Anaphylaxis from depot medroxyprogesterone acetate in an adolescent girl.","volume":"118","author":"Lestishock","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2025071714260425500_B91","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.contraception.2009.02.008","article-title":"Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons.","volume":"80","author":"Hubacher","year":"2009","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B92","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.contraception.2006.03.008","article-title":"Changes in bleeding patterns with depot medroxyprogesterone acetate subcutaneous injection 104 mg.","volume":"74","author":"Arias","year":"2006","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B93","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0010-7824(99)00104-3","article-title":"Factors affecting continuation rates of DMPA.","volume":"60","author":"Hubacher","year":"1999","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B94","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0010-7824(01)00181-0","article-title":"Effect of counseling to improve compliance in Mexican women receiving depot-medroxyprogesterone acetate.","volume":"63","author":"Canto De Cetina","year":"2001","journal-title":"Contraception"},{"issue":"4","key":"2025071714260425500_B95","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.contraception.2004.06.011","article-title":"Contraceptive efficacy and safety of DMPA-SC.","volume":"70","author":"Jain","year":"2004","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B96","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1001\/archpedi.160.1.40","article-title":"Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method.","volume":"160","author":"Bonny","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"2","key":"2025071714260425500_B97","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0010-7824(00)00144-X","article-title":"Depo-provera associated with weight gain in Navajo women.","volume":"62","author":"Espey","year":"2000","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B98","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S1054-139X(98)00151-7","article-title":"Weight change in adolescents who used hormonal contraception.","volume":"24","author":"Risser","year":"1999","journal-title":"J Adolesc Health"},{"key":"2025071714260425500_B99"},{"issue":"2","key":"2025071714260425500_B100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1083-3188(01)00147-4","article-title":"Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate.","volume":"15","author":"Mangan","year":"2002","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"2025071714260425500_B101","first-page":"CD008815","article-title":"Progestin-only contraceptives: effects on weight.","author":"Lopez","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2025071714260425500_B102","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.jadohealth.2009.04.009","article-title":"A longitudinal comparison of body composition changes in adolescent girls receiving hormonal contraception.","volume":"45","author":"Bonny","year":"2009","journal-title":"J Adolesc Health"},{"issue":"4","key":"2025071714260425500_B103","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/AOG.0b013e31820f387c","article-title":"Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate.","volume":"117","author":"Bonny","year":"2011","journal-title":"Obstet Gynecol"},{"issue":"2 pt 1","key":"2025071714260425500_B104","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/AOG.0b013e3181af68b2","article-title":"Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users.","volume":"114","author":"Le","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2025071714260425500_B105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0022-3476(96)70148-8","article-title":"A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.","volume":"129","author":"Cromer","year":"1996","journal-title":"J Pediatr"},{"issue":"1","key":"2025071714260425500_B106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jpag.2003.11.017","article-title":"Bone mineral density in adolescent females using depot medroxyprogesterone acetate.","volume":"17","author":"Lara-Torre","year":"2004","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"2025071714260425500_B107","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jadohealth.2004.07.005","article-title":"Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.","volume":"35","author":"Cromer","year":"2004","journal-title":"J Adolesc Health"},{"issue":"6","key":"2025071714260425500_B108","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jpag.2004.09.013","article-title":"Bone biochemical markers in adolescent girls using either depot medroxyprogesterone acetate or an oral contraceptive.","volume":"17","author":"Rome","year":"2004","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2025071714260425500_B109","volume-title":"DepoProvera 150 mg and Depo SubQ Provera 104 [package inserts]","year":"2005"},{"issue":"2","key":"2025071714260425500_B110","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/archpedi.159.2.139","article-title":"Change in bone mineral density among adolescent women using and discontinuing depot medroxyprogesterone acetate contraception.","volume":"159","author":"Scholes","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"2025071714260425500_B111","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2009.11.003","article-title":"Recovery of bone mineral density in adolescents following the use of depot medroxyprogesterone acetate contraceptive injections.","volume":"81","author":"Harel","year":"2010","journal-title":"Contraception"},{"issue":"4","key":"2025071714260425500_B112","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/AOG.0b013e3181875b78","article-title":"Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density.","volume":"112","author":"Berenson","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025071714260425500_B113","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2011.01.009","article-title":"Removing the black box warning for depot medroxyprogesterone acetate.","volume":"84","author":"Kaunitz","year":"2011","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B114","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.contraception.2008.07.014","article-title":"The effects of depot medroxyprogesterone acetate and intrauterine device use on fracture risk in Danish women.","volume":"78","author":"Vestergaard","year":"2008","journal-title":"Contraception"},{"issue":"11","key":"2025071714260425500_B115","doi-asserted-by":"crossref","first-page":"4909","DOI":"10.1210\/jc.2010-0032","article-title":"Use of depot medroxyprogesterone acetate and fracture risk.","volume":"95","author":"Meier","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2025071714260425500_B116","unstructured":"Institute of Medicine. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academies Press; 2010. Available at: www.iom.edu\/Reports\/2010\/Dietary-Reference-Intakes-for-calcium-and-vitamin-D.aspx. Accessed January 15, 2014"},{"issue":"3","key":"2025071714260425500_B117","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1542\/peds.2010-1564","article-title":"American Academy of Pediatrics. Clinical report\u2014gynecologic examination for adolescents in the pediatric office setting.","volume":"126","author":"Braverman","year":"2010","journal-title":"Pediatrics"},{"issue":"2","key":"2025071714260425500_B118","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.AOG.0000107298.29343.6a","article-title":"Combination estrogen-progestin contraceptives and body weight: systematic review of randomized controlled trials.","volume":"103","author":"Gallo","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025071714260425500_B119","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00404-012-2298-2","article-title":"Hormonal contraception and depression: a survey of the present state of knowledge.","volume":"286","author":"B\u00f6ttcher","year":"2012","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"2025071714260425500_B120","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1007\/s10508-007-9302-0","article-title":"The influence of hormonal contraception on mood and sexual interest among adolescents.","volume":"37","author":"Ott","year":"2008","journal-title":"Arch Sex Behav"},{"key":"2025071714260425500_B121","volume-title":"Managing Contraceptive Pill Patients","author":"Dickey","year":"2010"},{"issue":"4","key":"2025071714260425500_B122","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.cnur.2004.08.001","article-title":"Contraception for the adolescent and young adult with congenital heart disease.","volume":"39","author":"Canobbio","year":"2004","journal-title":"Nurs Clin North Am"},{"issue":"2","key":"2025071714260425500_B123","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1542\/peds.2010-2221","article-title":"Hormonal contraception and thrombotic risk: a multidisciplinary approach.","volume":"127","author":"Trenor","year":"2011","journal-title":"Pediatrics"},{"issue":"20","key":"2025071714260425500_B124","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJM200105173442007","article-title":"Oral contraceptives and the risk of venous thrombosis.","volume":"344","author":"Vandenbroucke","year":"2001","journal-title":"N Engl J Med"},{"key":"2025071714260425500_B125","unstructured":"US Food and Drug Administration. Updated information about the risk of blood clots in women taking birth control pills containing drospirenone. Silver Spring, MD: US Food and Drug Administration; 2012. Available at: www.fda.gov\/Drugs\/DrugSafety\/ucm299305.htm. Accessed January 15, 2014"},{"key":"2025071714260425500_B126","doi-asserted-by":"crossref","first-page":"b2921","DOI":"10.1136\/bmj.b2921","article-title":"The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control study.","volume":"339","author":"van Hylckama Vlieg","year":"2009","journal-title":"BMJ"},{"issue":"4","key":"2025071714260425500_B127","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jpeds.2004.06.021","article-title":"Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey.","volume":"145","author":"Stein","year":"2004","journal-title":"J Pediatr"},{"issue":"1","key":"2025071714260425500_B128","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1055\/s-2003-38330","article-title":"Venous and arterial thrombosis during pregnancy: epidemiology.","volume":"3","author":"Walker","year":"2003","journal-title":"Semin Vasc Med"},{"issue":"10","key":"2025071714260425500_B129","doi-asserted-by":"crossref","first-page":"697","DOI":"10.7326\/0003-4819-143-10-200511150-00006","article-title":"Trends in the incidence of venous thromboembolism during pregnancy or postpartum: a 30-year population-based study.","volume":"143","author":"Heit","year":"2005","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025071714260425500_B130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2010.06.013","article-title":"The use of hormonal contraception among women taking anticonvulsant therapy.","volume":"83","author":"Gaffield","year":"2011","journal-title":"Contraception"},{"issue":"5 Pt 1","key":"2025071714260425500_B131","first-page":"853","article-title":"Council on Scientific Affairs, American Medical Association. Drug interactions between oral contraceptives and antibiotics","volume":"98","author":"Dickinson","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2025071714260425500_B132","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.contraception.2010.08.020","article-title":"Antibiotics and oral contraceptive failure\u2014a case-crossover study.","volume":"83","author":"Toh","year":"2011","journal-title":"Contraception"},{"issue":"5","key":"2025071714260425500_B133","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1083-3188(02)00188-2","article-title":"Extended cycling of oral contraceptive pills for adolescents.","volume":"15","author":"Sucato","year":"2002","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"2025071714260425500_B134","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/01.gco.0000178436.33998.8f","article-title":"Extended cycle hormonal contraception in adolescents.","volume":"17","author":"Sucato","year":"2005","journal-title":"Curr Opin Obstet Gynecol"},{"issue":"4","key":"2025071714260425500_B135","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.jadohealth.2011.01.015","article-title":"Autism spectrum disorders and menstruation.","volume":"49","author":"Hamilton","year":"2011","journal-title":"J Adolesc Health"},{"issue":"4","key":"2025071714260425500_B136","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.ajog.2004.02.012","article-title":"Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.","volume":"190","author":"Schlaff","year":"2004","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"2025071714260425500_B137","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.contraception.2005.09.009","article-title":"Ovarian follicular dynamics during conventional vs. continuous oral contraceptive use.","volume":"73","author":"Birtch","year":"2006","journal-title":"Contraception"},{"issue":"5","key":"2025071714260425500_B138","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.contraception.2004.05.006","article-title":"Ovarian follicular development is initiated during the hormone-free interval of oral contraceptive use.","volume":"70","author":"Baerwald","year":"2004","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B139","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.","volume":"107","author":"ACOG Committee on Practice Bulletins-Gynecology","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025071714260425500_B140","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004.","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"issue":"6","key":"2025071714260425500_B141","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.contraception.2007.07.013","article-title":"The contraceptive vaginal ring: female adolescents\u2019 knowledge, attitudes and plans for use.","volume":"76","author":"Carey","year":"2007","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B142","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/01.AOG.0000136082.59644.13","article-title":"A comparison between the vaginal ring and oral contraceptives.","volume":"104","author":"Veres","year":"2004","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025071714260425500_B143","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.contraception.2005.03.012","article-title":"In vivo assessment of NuvaRing placement.","volume":"72","author":"Barnhart","year":"2005","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B144","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.contraception.2003.10.014","article-title":"The combined contraceptive vaginal ring, NuvaRing, and tampon co-usage.","volume":"69","author":"Verhoeven","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"2025071714260425500_B145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0010-7824(03)00002-7","article-title":"The combined contraceptive ring NuvaRing and spermicide co-medication.","volume":"67","author":"Haring","year":"2003","journal-title":"Contraception"},{"issue":"2","key":"2025071714260425500_B146","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.contraception.2003.10.001","article-title":"The contraceptive vaginal ring, NuvaRing, and antimycotic co-medication.","volume":"69","author":"Verhoeven","year":"2004","journal-title":"Contraception"},{"issue":"4","key":"2025071714260425500_B147","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/humrep\/deh686","article-title":"Effects of two types of hormonal contraception\u2014oral versus intravaginal\u2014on the sexual life of women and their partners.","volume":"20","author":"Guida","year":"2005","journal-title":"Hum Reprod"},{"issue":"3","key":"2025071714260425500_B148","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/humrep\/16.3.469","article-title":"Efficacy, tolerability and acceptability of a novel contraceptive vaginal ring releasing etonogestrel and ethinyl oestradiol.","volume":"16","author":"Roumen","year":"2001","journal-title":"Hum Reprod"},{"issue":"3","key":"2025071714260425500_B149","first-page":"585","article-title":"Efficacy, cycle control, and user acceptability of a novel combined contraceptive vaginal ring.","volume":"100","author":"Dieben","year":"2002","journal-title":"Obstet Gynecol"},{"issue":"2","key":"2025071714260425500_B150","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0030-1248138","article-title":"The contraceptive vaginal ring.","volume":"28","author":"Edwardson","year":"2010","journal-title":"Semin Reprod Med"},{"issue":"10","key":"2025071714260425500_B151","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1093\/humrep\/dei117","article-title":"The combined contraceptive vaginal ring and bone mineral density in healthy pre-menopausal women.","volume":"20","author":"Massai","year":"2005","journal-title":"Hum Reprod"},{"issue":"3","key":"2025071714260425500_B152","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.contraception.2009.09.011","article-title":"Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.","volume":"81","author":"Massaro","year":"2010","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B153","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.contraception.2005.03.005","article-title":"Comparison of ethinylestradiol pharmacokinetics in three hormonal contraceptive formulations: the vaginal ring, the transdermal patch and an oral contraceptive.","volume":"72","author":"van den Heuvel","year":"2005","journal-title":"Contraception"},{"issue":"3","key":"2025071714260425500_B154","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.thromres.2008.04.022","article-title":"Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study.","volume":"123","author":"Fleischer","year":"2009","journal-title":"Thromb Res"},{"issue":"6","key":"2025071714260425500_B155","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.contraception.2008.07.004","article-title":"Effects of switching from oral to transdermal or transvaginal contraception on markers of thrombosis.","volume":"78","author":"Jensen","year":"2008","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B156","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.contraception.2009.05.131","article-title":"Effects of the contraceptive vaginal ring, the contraceptive transdermal patch and combined oral contraceptives on markers of hemostasis.","volume":"81","author":"van Vliet","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B157","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jpag.2007.06.001","article-title":"Adolescent and young women\u2019s experience with the vaginal ring and oral contraceptive pills.","volume":"20","author":"Stewart","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"2025071714260425500_B158","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/AOG.0b013e3181cf45dc","article-title":"Adherence and acceptability of the contraceptive ring compared with the pill among students: a randomized controlled trial.","volume":"115","author":"Gilliam","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025071714260425500_B159","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2165\/00003088-200039030-00005","article-title":"Pharmacokinetics of etonogestrel and ethinylestradiol released from a combined contraceptive vaginal ring.","volume":"39","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"2025071714260425500_B160","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/01.AOG.0000175144.08035.74","article-title":"Extended regimens of the contraceptive vaginal ring: a randomized trial.","volume":"106","author":"Miller","year":"2005","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025071714260425500_B161","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0b013e3181842071","article-title":"Frequency and management of breakthrough bleeding with continuous use of the transvaginal contraceptive ring: a randomized controlled trial.","volume":"112","author":"Sulak","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"29","key":"2025071714260425500_B162","first-page":"1","article-title":"Use of contraception in the United States: 1982-2008.","author":"Mosher","year":"2010","journal-title":"Vital Health Stat 23"},{"issue":"6","key":"2025071714260425500_B163","first-page":"1449]","article-title":"Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users [published correction appears in","volume":"111","author":"Cole","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"5","key":"2025071714260425500_B164","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.contraception.2009.12.009","article-title":"Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users.","volume":"81","author":"Dore","year":"2010","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B165","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/AOG.0b013e3181aa92ee","article-title":"Eligibility criteria in venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.","volume":"114","author":"Dore","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025071714260425500_B166","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.contraception.2007.03.003","article-title":"Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.","volume":"76","author":"Jick","year":"2007","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B167","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.contraception.2009.07.004","article-title":"Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptives containing hormonal contraceptives with 30 mcg of ethinyl estradiol in relation to nonfatal venous thromboembolism.","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"issue":"5","key":"2025071714260425500_B168","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.contraception.2009.12.016","article-title":"ORTHO EVRA and venous thromboembolism: an update.","volume":"81","author":"Jick","year":"2010","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B169","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.contraception.2006.02.002","article-title":"Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.","volume":"73","author":"Jick","year":"2006","journal-title":"Contraception"},{"issue":"1","key":"2025071714260425500_B170","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.contraception.2012.09.015","article-title":"Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.","volume":"87","author":"Sidney","year":"2013","journal-title":"Contraception"},{"issue":"2","key":"2025071714260425500_B171","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejogrb.2005.01.021","article-title":"Contraceptive efficacy, compliance and beyond: factors related to satisfaction with once-weekly transdermal compared with oral contraception.","volume":"121","author":"Urdl","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"4","key":"2025071714260425500_B172","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S1701-2163(16)30462-5","article-title":"Preference for and satisfaction of Canadian women with the transdermal contraceptive patch versus previous contraceptive method: an open-label, multicentre study.","volume":"27","author":"Weisberg","year":"2005","journal-title":"J Obstet Gynaecol Can"},{"issue":"2","key":"2025071714260425500_B173","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S0015-0282(01)03263-0","article-title":"Assessment of compliance with a weekly contraceptive patch (Ortho Evra\/Evra) among North American women.","volume":"77","author":"Archer","year":"2002","journal-title":"Fertil Steril"},{"issue":"3","key":"2025071714260425500_B174","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.contraception.2003.10.006","article-title":"The impact of improved compliance with a weekly contraceptive transdermal system (Ortho Evra) on contraceptive efficacy.","volume":"69","author":"Archer","year":"2004","journal-title":"Contraception"},{"issue":"2","key":"2025071714260425500_B175","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jpag.2004.11.016","article-title":"Adolescents\u2019 experience with the combined estrogen and progestin transdermal contraceptive method Ortho Evra.","volume":"18","author":"Harel","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"5","key":"2025071714260425500_B176","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1054-139X(03)00367-7","article-title":"An evaluation of the use of the transdermal contraceptive patch in adolescents.","volume":"34","author":"Rubinstein","year":"2004","journal-title":"J Adolesc Health"},{"issue":"2","key":"2025071714260425500_B177","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.AOG.0000228850.85346.e2","article-title":"Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population.","volume":"108","author":"Bakhru","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025071714260425500_B178","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1097\/01.AOG.0000250057.47645.25","article-title":"Performance of contraceptive patch compared with oral contraceptive pill in a high-risk population.","volume":"108","author":"LaGuardia","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2025071714260425500_B179","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jpag.2011.02.001","article-title":"Adolescents\u2019 experiences using the contraceptive patch versus pills.","volume":"24","author":"Sucato","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2025071714260425500_B180","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1100\/tsw.2004.107","article-title":"Long-term evaluation of the use of the transdermal contraceptive patch in adolescents.","volume":"4","author":"Logsdon","year":"2004","journal-title":"ScientificWorldJournal"},{"issue":"2","key":"2025071714260425500_B181","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.jpag.2006.11.006","article-title":"Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch?","volume":"20","author":"Thurman","year":"2007","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"3","key":"2025071714260425500_B182","first-page":"CD003552","article-title":"Skin patch and vaginal ring versus combined oral contraceptives for contraception.","author":"Lopez","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"2 pt 1","key":"2025071714260425500_B183","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/01.AOG.0000298338.58511.d1","article-title":"Multicenter comparison of the contraceptive ring and patch: a randomized controlled trial.","volume":"111","author":"Creinin","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025071714260425500_B184","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jpeds.2005.12.010","article-title":"Allergic contact dermatitis due to transdermal contraception patch.","volume":"148","author":"Stricker","year":"2006","journal-title":"J Pediatr"},{"issue":"3","key":"2025071714260425500_B185","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.jadohealth.2009.02.007","article-title":"Attitudes toward the vaginal ring and transdermal patch among adolescents and young women.","volume":"45","author":"Raine","year":"2009","journal-title":"J Adolesc Health"},{"issue":"4","key":"2025071714260425500_B186","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jadohealth.2011.01.008","article-title":"Transdermal contraception as a model for adolescent use of new methods.","volume":"49","author":"Sucato","year":"2011","journal-title":"J Adolesc Health"},{"issue":"1","key":"2025071714260425500_B187","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jpag.2009.04.008","article-title":"Bone accretion in adolescents using the combined estrogen and progestin transdermal contraceptive method Ortho Evra: a pilot study.","volume":"23","author":"Harel","year":"2010","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"31","key":"2025071714260425500_B188","first-page":"1","article-title":"Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth.","author":"Martinez","year":"2011","journal-title":"Vital Health Stat 23"},{"key":"2025071714260425500_B189","unstructured":"Centers for Disease Control and Prevention. Male latex condoms and sexually transmitted diseases: condom fact sheet in brief. Atlanta, GA: Centers for Disease Control and Prevention. Available at: www.cdc.gov\/condomeffectiveness\/brief.html. Accessed January 15, 2014"},{"issue":"6","key":"2025071714260425500_B190","first-page":"454","article-title":"Effectiveness of condoms in preventing sexually transmitted infections.","volume":"82","author":"Holmes","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"10","key":"2025071714260425500_B191","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/OLQ.0b013e318073bd71","article-title":"Self-reported condom use is associated with reduced risk of chlamydia, gonorrhea, and trichomoniasis.","volume":"34","author":"Gallo","year":"2007","journal-title":"Sex Transm Dis"},{"issue":"3","key":"2025071714260425500_B192","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1136\/sti.2005.018978","article-title":"Condom effectiveness for prevention of C trachomatis infection.","volume":"82","author":"Warner","year":"2006","journal-title":"Sex Transm Infect"},{"issue":"6","key":"2025071714260425500_B193","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1001\/archpedi.159.6.536","article-title":"The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents.","volume":"159","author":"Paz-Bailey","year":"2005","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"4","key":"2025071714260425500_B194","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/sti.2004.012799","article-title":"Condom effectiveness for prevention of Chlamydia trachomatis infection.","volume":"81","author":"Niccolai","year":"2005","journal-title":"Sex Transm Infect"},{"issue":"1","key":"2025071714260425500_B195","first-page":"CD003255","article-title":"Condom effectiveness in reducing heterosexual HIV transmission.","author":"Weller","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"issue":"13","key":"2025071714260425500_B196","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1001\/archinternmed.2009.177","article-title":"A pooled analysis of the effect of condoms in preventing HSV-2 acquisition.","volume":"169","author":"Martin","year":"2009","journal-title":"Arch Intern Med"},{"issue":"5","key":"2025071714260425500_B197","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/OLQ.0b013e318248aa8a","article-title":"Case-crossover analysis of condom use and herpes simplex virus type 2 acquisition.","volume":"39","author":"Stanaway","year":"2012","journal-title":"Sex Transm Dis"},{"issue":"25","key":"2025071714260425500_B198","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa053284","article-title":"Condom use and the risk of genital human papillomavirus infection in young women.","volume":"354","author":"Winer","year":"2006","journal-title":"N Engl J Med"},{"issue":"2","key":"2025071714260425500_B199","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archpedi.160.2.151","article-title":"Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women.","volume":"160","author":"Shew","year":"2006","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"7","key":"2025071714260425500_B200","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/OLQ.0b013e3181a396eb","article-title":"A systematic review of epidemiologic studies assessing condom use and risk of syphilis.","volume":"36","author":"Koss","year":"2009","journal-title":"Sex Transm Dis"},{"issue":"5","key":"2025071714260425500_B201","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1542\/peds.2013-2821","article-title":"Policy statement: condom use by adolescents.","volume":"132","author":"American Academy of Pediatrics, Committee on Adolescence","year":"2013","journal-title":"Pediatrics"},{"issue":"4","key":"2025071714260425500_B202","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jadohealth.2010.07.016","article-title":"Developmental changes in condom use among urban adolescent females: influence of partner context.","volume":"48","author":"Matson","year":"2011","journal-title":"J Adolesc Health"},{"key":"2025071714260425500_B203","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1097\/NNR.0b013e318217145c","article-title":"Adolescent condom use consistency over time: global versus partner-specific measures.","volume":"60","author":"Bearinger","year":"2011","journal-title":"Nurs Res"},{"issue":"4","key":"2025071714260425500_B204","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.pedhc.2009.06.014","article-title":"Individual, interpersonal, and relationship factors predicting hormonal and condom use consistency among adolescent girls.","volume":"24","author":"Kenyon","year":"2010","journal-title":"J Pediatr Health Care"},{"issue":"3","key":"2025071714260425500_B205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1363\/4118109","article-title":"Relationship dynamics and consistency of condom use among adolescents.","volume":"41","author":"Manning","year":"2009","journal-title":"Perspect Sex Reprod Health"},{"issue":"6","key":"2025071714260425500_B206","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2307\/2135889","article-title":"The dynamics of young men\u2019s condom use during and across relationships.","volume":"26","author":"Ku","year":"1994","journal-title":"Fam Plann Perspect"},{"issue":"2","key":"2025071714260425500_B207","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2105\/AJPH.92.2.211","article-title":"Condom use as a function of time in new and established adolescent sexual relationships.","volume":"92","author":"Fortenberry","year":"2002","journal-title":"Am J Public Health"},{"issue":"2 pt 1","key":"2025071714260425500_B208","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1097\/AOG.0b013e3181c8e2aa","article-title":"Ulipristal acetate taken 48-120 hours after intercourse for emergency contraception.","volume":"115","author":"Fine","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"9714","key":"2025071714260425500_B209","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(10)60101-8","article-title":"Ulipristal acetate versus levonorgestrel for emergency contraception: a randomised non-inferiority trial and meta-analysis.","volume":"375","author":"Glasier","year":"2010","journal-title":"Lancet"},{"issue":"4","key":"2025071714260425500_B210","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.contraception.2011.02.009","article-title":"Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel.","volume":"84","author":"Glasier","year":"2011","journal-title":"Contraception"},{"key":"2025071714260425500_B211","unstructured":"Rockoff JD. FDA reviewing efficacy of Plan B contraception in women over 165 pounds. The Wall Street Journal. November 25, 2013. Available at: http:\/\/online.wsj.com\/news\/articles\/SB10001424052702304011304579220533719517944. Accessed January 15, 2014"},{"issue":"11","key":"2025071714260425500_B212","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1056\/NEJMsb020913","article-title":"Switching emergency contraception to over-the-counter status.","volume":"347","author":"Grimes","year":"2002","journal-title":"N Engl J Med"},{"issue":"6","key":"2025071714260425500_B213","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1542\/peds.2012-2962","article-title":"Emergency contraception.","volume":"130","author":"Committee on Adolescence","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"2025071714260425500_B214","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/j.1875-9114.2012.01041.x","article-title":"Measuring and reporting of the treatment effect of hormonal emergency contraceptives.","volume":"32","author":"Leung","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"4","key":"2025071714260425500_B215","first-page":"570","article-title":"Emergency contraception: randomized comparison of advance provision and information only.","volume":"98","author":"Ellertson","year":"2001","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025071714260425500_B216","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpag.2010.06.002","article-title":"Advance provision of emergency contraception among adolescent and young adult women: a systematic review of literature.","volume":"24","author":"Meyer","year":"2011","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"4","key":"2025071714260425500_B217","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jurban\/jtg072","article-title":"Knowledge of, attitudes toward, and stage of change for female and male condoms among Denver inner-city women.","volume":"80","author":"Bull","year":"2003","journal-title":"J Urban Health"},{"issue":"10","key":"2025071714260425500_B218","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S1473-3099(02)00396-1","article-title":"Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women.","volume":"2","author":"Wilkinson","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"2025071714260425500_B219","unstructured":"Today Sponge\u2014Vaginal Contraceptive Sponge [consumer information leaflet]. Berkeley, CA: Myer Laboratories Inc; 2011. Available at: http:\/\/todaysponge.com\/pdf\/todaysponge-pi2.pdf. Accessed January 15, 2014"},{"issue":"4","key":"2025071714260425500_B220","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.contraception.2008.05.007","article-title":"Discontinuation and resumption of contraceptive use: results from the 2002 National Survey of Family Growth.","volume":"78","author":"Vaughan","year":"2008","journal-title":"Contraception"},{"issue":"4","key":"2025071714260425500_B221","first-page":"CD004860","article-title":"Fertility awareness-based methods for contraception.","author":"Grimes","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2025071714260425500_B222","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1363\/4210210","article-title":"Withdrawal attitudes and experiences: a qualitative perspective among young urban adults.","volume":"42","author":"Whittaker","year":"2010","journal-title":"Perspect Sex Reprod Health"},{"issue":"1","key":"2025071714260425500_B223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10995-007-0220-5","article-title":"What is the prevalence of children with special health care needs? Toward an understanding of variations in findings and methods across three national surveys.","volume":"12","author":"Bethell","year":"2008","journal-title":"Matern Child Health J"},{"issue":"6","key":"2025071714260425500_B224","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ypmed.2010.09.006","article-title":"Reproductive health of young adults with physical disabilities in the U.S.","volume":"51","author":"McRee","year":"2010","journal-title":"Prev Med"},{"issue":"2","key":"2025071714260425500_B225","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/1054-139X(95)00282-W","article-title":"Sexual behavior of adolescents with chronic disease and disability.","volume":"19","author":"Sur\u00eds","year":"1996","journal-title":"J Adolesc Health"},{"issue":"9","key":"2025071714260425500_B226","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1469-8749.2005.tb01220.x","article-title":"Sexuality in children and adolescents with disabilities.","volume":"47","author":"Murphy","year":"2005","journal-title":"Dev Med Child Neurol"},{"issue":"4","key":"2025071714260425500_B227","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1047-9651(02)00045-1","article-title":"Adolescent sexuality and disability.","volume":"13","author":"Neufeld","year":"2002","journal-title":"Phys Med Rehabil Clin N Am"},{"issue":"5","key":"2025071714260425500_B228","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1542\/peds.110.5.897","article-title":"Secondary sexual characteristics in children with cerebral palsy and moderate to severe motor impairment: a cross-sectional survey.","volume":"110","author":"Worley","year":"2002","journal-title":"Pediatrics"},{"issue":"2","key":"2025071714260425500_B229","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/jnnp.73.2.121","article-title":"Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management.","volume":"73","author":"Bauer","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"2025071714260425500_B230","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jpag.2005.03.002","article-title":"Menstrual and contraceptive issues among young women with developmental delay: a retrospective review of cases at the Hospital for Sick Children, Toronto.","volume":"18","author":"Dizon","year":"2005","journal-title":"J Pediatr Adolesc Gynecol"},{"issue":"6","key":"2025071714260425500_B231","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/AOG.0b013e3181c6f922","article-title":"ACOG Committee Opinion No. 448: Menstrual manipulation for adolescents with disabilities.","volume":"114","author":"American College of Obstetricians and Gynecologists Committee on Adolescent Health Care","year":"2009","journal-title":"Obstet Gynecol"},{"key":"2025071714260425500_B232","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1196\/annals.1429.020","article-title":"Menstrual issues in adolescents with physical and developmental disabilities.","volume":"1135","author":"Quint","year":"2008","journal-title":"Ann N Y Acad Sci"},{"issue":"2","key":"2025071714260425500_B233","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.0004-8666.2003.00046.x","article-title":"Consensus statement: Menstrual and contraceptive management in women with an intellectual disability.","volume":"43","author":"Atkinson","year":"2003","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"5","key":"2025071714260425500_B234","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2008-2797","article-title":"Exploring the relationship among weight, race, and sexual behaviors among girls.","volume":"124","author":"Akers","year":"2009","journal-title":"Pediatrics"},{"issue":"4","key":"2025071714260425500_B235","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.jadohealth.2010.07.022","article-title":"Obesity, body dissatisfaction, and emotional well-being in early and late adolescence: findings from the project EAT study.","volume":"48","author":"Mond","year":"2011","journal-title":"J Adolesc Health"},{"issue":"18","key":"2025071714260425500_B236","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1001\/jama.285.18.2347","article-title":"Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial.","volume":"285","author":"Audet","year":"2001","journal-title":"JAMA"},{"issue":"2","key":"2025071714260425500_B237","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1016\/S0015-0282(01)03275-7","article-title":"Contraceptive efficacy and cycle control with the Ortho Evra\/Evra transdermal system: the analysis of pooled data.","volume":"77","author":"Zieman","year":"2002","journal-title":"Fertil Steril"},{"issue":"1","key":"2025071714260425500_B238","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/AOG.0b013e318259565a","article-title":"Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women.","volume":"120","author":"Xu","year":"2012","journal-title":"Obstet Gynecol"},{"issue":"11","key":"2025071714260425500_B239","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1093\/aje\/kwm221","article-title":"Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth.","volume":"166","author":"Brunner Huber","year":"2007","journal-title":"Am J Epidemiol"},{"issue":"5","key":"2025071714260425500_B240","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1097\/AOG.0b013e3181f81ccf","article-title":"Hormonal contraceptives for contraception in overweight or obese women.","volume":"116","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"4","key":"2025071714260425500_B241","first-page":"CD003987","article-title":"Combination contraceptives: effects on weight.","author":"Gallo","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2025071714260425500_B242","first-page":"CD008815","article-title":"Progestin-only contraceptives: effects on weight.","author":"Lopez","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2025071714260425500_B243","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.contraception.2013.03.004","article-title":"Weight change at 12 months in users of three progestin-only contraceptive methods.","volume":"88","author":"Vickery","year":"2013","journal-title":"Contraception"},{"issue":"6","key":"2025071714260425500_B244","first-page":"1306","article-title":"ACOG practice bulletin no. 105: Bariatric surgery and pregnancy.","volume":"113","author":"American College of Obstetricians and Gynecologists","year":"2009","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"24","key":"2025071714260425500_B245","first-page":"449","article-title":"Update to CDC\u2019s U.S. Medical Eligibility Criteria for Contraceptive Use, 2010: revised recommendations for the use of hormonal contraception among women at high risk for HIV infection or infected with HIV.","volume":"61","author":"Tepper","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025071714260425500_B246","unstructured":"Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Washington, DC: Department of Health and Human Services; 2011. Updated February 2013. Available at: www.aidsinfo.nih.gov\/ContentFiles\/AdultandAdolescentGL.pdf. Accessed January 15, 2014"},{"issue":"4","key":"2025071714260425500_B247","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0899-5885(18)30245-4","article-title":"Cardiac transplantation in women.","volume":"9","author":"Cupples","year":"1997","journal-title":"Crit Care Nurs Clin North Am"},{"issue":"6","key":"2025071714260425500_B248","first-page":"1083","article-title":"Pregnancy and liver transplantation.","volume":"76","author":"Laifer","year":"1990","journal-title":"Obstet Gynecol"},{"issue":"6","key":"2025071714260425500_B249","first-page":"663","article-title":"Psychosocial issues in kidney-transplanted children and adolescents: literature review.","volume":"20","author":"Shaben","year":"1993","journal-title":"ANNA J"},{"issue":"1","key":"2025071714260425500_B250","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/adc.63.1.35","article-title":"Long term outcome of treatment of end stage renal failure.","volume":"63","author":"Henning","year":"1988","journal-title":"Arch Dis Child"},{"issue":"4","key":"2025071714260425500_B251","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/0197-0070(89)90063-6","article-title":"Characteristics of social networks in adolescents with end-stage renal disease treated with renal transplantation.","volume":"10","author":"Melzer","year":"1989","journal-title":"J Adolesc Health Care"},{"issue":"1","key":"2025071714260425500_B252","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00007890-199107000-00010","article-title":"Long-term quality of life after kidney transplantation in childhood.","volume":"52","author":"Morel","year":"1991","journal-title":"Transplantation"},{"issue":"8","key":"2025071714260425500_B253","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1016\/S0041-1345(99)00757-5","article-title":"Postrenal transplant improvement of sexual function.","volume":"31","author":"Ghahramani","year":"1999","journal-title":"Transplant Proc"},{"issue":"11","key":"2025071714260425500_B254","first-page":"610","article-title":"Contraception in the female transplant recipient.","volume":"15","author":"O'Donnell","year":"1986","journal-title":"Dial Transplant"},{"issue":"7","key":"2025071714260425500_B255","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1016\/S0041-1345(98)00928-2","article-title":"Kidney transplantation and menstrual changes.","volume":"30","author":"Kim","year":"1998","journal-title":"Transplant Proc"},{"issue":"5","key":"2025071714260425500_B256","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archpedi.154.5.478","article-title":"Improving rheumatologists\u2019 screening for alcohol use and sexual activity.","volume":"154","author":"Britto","year":"2000","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"11","key":"2025071714260425500_B257","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1053\/jlts.2001.28644","article-title":"Contraception and pregnancy after liver transplantation.","volume":"7","author":"Riely","year":"2001","journal-title":"Liver Transpl"},{"issue":"9","key":"2025071714260425500_B258","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1016\/j.transproceed.2007.09.014","article-title":"Oral and transdermal hormonal contraception in women after kidney transplantation.","volume":"39","author":"Pietrzak","year":"2007","journal-title":"Transplant Proc"},{"issue":"4","key":"2025071714260425500_B259","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.transproceed.2010.03.132","article-title":"The contraceptive vaginal ring in women with renal and liver transplantation: analysis of preliminary results.","volume":"42","author":"Paternoster","year":"2010","journal-title":"Transplant Proc"},{"issue":"5","key":"2025071714260425500_B260","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.transproceed.2007.02.063","article-title":"Low-dose hormonal contraception after liver transplantation.","volume":"39","author":"Jabiry-Zieniewicz","year":"2007","journal-title":"Transplant Proc"},{"issue":"8525","key":"2025071714260425500_B261","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(87)91988-X","article-title":"Oral contraceptive interaction with cyclosporin.","volume":"1","author":"Deray","year":"1987","journal-title":"Lancet"},{"issue":"2","key":"2025071714260425500_B262","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ogc.2004.03.005","article-title":"Pregnancy after organ transplant.","volume":"31","author":"Mastrobattista","year":"2004","journal-title":"Obstet Gynecol Clin North Am"},{"issue":"6","key":"2025071714260425500_B263","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1053\/j.semperi.2007.09.007","article-title":"Contraception for the transplant patient.","volume":"31","author":"Estes","year":"2007","journal-title":"Semin Perinatol"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/4\/e1257\/1702885\/peds_2014-2300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/134\/4\/e1257\/1702885\/peds_2014-2300.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T18:26:35Z","timestamp":1752776795000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/134\/4\/e1257\/33010\/Contraception-for-Adolescents"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":263,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,10,1]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2014-2300","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}